SlideShare a Scribd company logo
Journal Club
Murtaza Kamal
18/04/2019
Role of QRS fragmentation for risk
stratification in adults with TOF
J Am Heart Assoc., Nov 2018
Introduction
• Adults with repaired TOF—> Reduced survival compared to general
population
• 30 yrs survival: 85-90%
• Risk stratification imp—> To identify+ treat patients with high risk of
CV death
• 2. Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, McGoon DC,Kirklin JW, Danielson GK. Long-term outcome in patients undergoing surgicalrepair of tetralogy
of Fallot. N Engl J Med. 1993;329:593–599.
3. Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Schreier J, GatzoulisMA, Groenink M, Inuzuka R, Kilner PJ, Koyak Z, Landzberg MJ, Mulder B, Powell
AJ, Wald R, Geva T. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled
in the INDICATOR cohort. Heart. 2014;100:247–253.
4. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Longterm survival in patients with repair of tetralogy of Fallot: 36-year follow-up of490 survivors of the first
year after surgical repair. J Am Coll Cardiol.1997;30:1374–1383.
5. Katz NM, Blackstone EH, Kirklin JW, Pacifico AD, Bargeron LM Jr. Late survival and symptoms after repair of tetralogy of Fallot. Circulation. 1982;65:
403–410.
Intro cont…
• Proposed risk factors for mortality in aduts with repaired TOF:
• Age at time of repair
• LV/ RV dysfunction
• RV fibrosis/ RVH
• Ventricular arrhythmias
• Increased LVEDP
Intro cont…
• Available risk scores includes variables from CMR/ Cardiac cath—> Not
routinely performed during annual evaluation
• ECG: Inexpensive/ Non invasive/ Readily available/ Routinely
performed during annual examination
• 2017: Bokma et al: QRS-f reliably predicts mortality in this population
• Bokma JP, Winter MM, Vehmeijer JT, Vliegen HW, van Dijk AP, van Melle JP,Meijboom FJ, Post MC, Zwinderman AH, Mulder BJ, Bouma BJ. QRSfragmentation is superior to QRS
duration in predicting mortality in adultswith tetralogy of Fallot. Heart. 2017;103:666–671.
Aim of study…
• To determine whether QRS-f derived from a standard 12 leads ECG
could independently predict mortality in a different population of
adults with TOF
Patient selection…
• Mayo adult CHD database
• > 18 y, repaired TOF
• At least 1 ECG b/w 1/1/1990 to 31/12/2017 (28 y)
• PA: Excluded
Data collection…
• Clinical notes/ ECG/ Holter/ ECHO/ Exercise test/ Surgical records/
CMR—> Reviewed
• 1st ECG during study period: Baseline—> Used for assessment of QRS-f
• Clinical data obtained within 12 months of baseline ECG—> Baseline
characteristics
• ECGs analysed by 2 observers: NM/ MF—> Blinded—> If discordance—>
3rd assesses AD
QRS-f
• If QRS duration < 120 ms:
• An additional R wave (R’) or notch in nadir of S in ≥ 2 contagious leads
• Rt sided/ septal: aVR, V1, V2
• Anterior: V2-V5
• Lateral: I, aVL, V5, V6
• Inferior: II, III, aVF
• In pts with RBBB:
• ≥ 3 R waves/ notes in R/S complexes in ≥2 contiguous leads
• In pts with paced QRS+ PVC:
• ≥ 3 notches in the R/S complexes
QRS-f
QRS-f Severity
• No of leads with QRS-f:
• NONE
• MILD: ≤ 3 leads
• MODERATE: 4 leads
• SEVERE: ≥5 leads
• For assessment of progression of QRS-f: Review of ECGs in its with at
least 5 years of follow up
Results
• 465 pts
• Age at time of baseline ECG: 37 ± 14y
• 223 (48%): Men
• 41 (9%): Pacemakers
• 58 (13%): Defibrillators
• 100 (22%): H/o VT
ECG
• Baseline ECG rhythm:
• Sinus: 407 (88%)
• Atrial flutter/ tachycardia: 20 (4%)
• Atrial and/ or ventricular paced rhythm: 21 (5%)
• HR: 74 ± 9bpm
• QRS duration: 148± 33ms
• QRS morphology:
• Normal: 9 (2%)
• iRBBB: 102 (22%)
• RBBB: 354 (76%)
ECG cont…
• QRS-f: 161 (35%)
• Mild: 43 (9%)
• Moderate: 77(17%)
• Severe: 41 (9%)
• Pts with QRS-f:
• Had longer QRS durations: 167±31 vs 126±24 ms, p=0.001
• Were older at time of repair: 7±6 vs 4±3y, p=0.023
• 371 (80%): ECG at 5 y follow up
• 39 (11%): Progression of QRS-f (No—> Mild: 34; Mild —>
MODERATE: 5)
Outcomes
• 55 deaths: 12%; Follow up period: 13.6±8.2 y
• CHF: 13 (24%)
• Arrhythmic/ sudden death: 11 (20%)
• Post op death after cardiac sx: 3 (6%)
• MODS by sepsis:4 (7%)
• Malignancy: 5 (9%)
• GI bleed: 1 (2%)
• Stroke: 2 (4%)
• Unknown/ Mixed: 16 (29%)
Outcomes cont…
• 20 yrs survival:
• Group without QRS-f: 97%
• Mild QRS-f: 93%; p=0.643
• Moderate QRS-f: 82%; p=0.031
• Severe QRS-f: 33%; p<0.001
• Severity of QRS-f: An independent predictor for all cause
mortality after adjustment for other ECG parameters, pt
demographics, vent. Function and h/o atrial/ ventricular arrhythmias
Discussion
• QRS duration> 180 ms: Risk factor of sudden death
• Bokma et al: QRS-f superior in prediction of all cause mortality
• This study: In a different population (US vs Dutch)
• Moderate/ severe QRS-f: 2 fold increase in risk of all cause mortality,
had reduced 20y survival
QRS-f as a marker of
ventricular dysfunction
• Studies with QRS-f of lt precordial leads—> Associated with
myocardial scar + LV aneurysm in its with CAD (Severity co-relates
with extent of scar)
• QRS-f in anterior leads—> Associated with RV dysfunction+ RVOT
aneurysm in TOF pts
• A marker of myocardial fibrosis—> LGE in CMR
• Das MK, Khan B, Jacob S, Kumar A, Mahenthiran J. Significance of a fragmented QRS complex versus a Q wave in patients with coronary arterydisease. Circulation.
2006;113:2495–2501.
14. Reddy CV, Cheriparambill K, Saul B, Makan M, Kassotis J, Kumar A, Das MK.Fragmented left sided QRS in absence of bundle branch block: sign of leftventricular aneurysm. Ann Noninvasive
Electrocardiol. 2006;11:132–138.
15. Shanmugam N, Yap J, Tan RS, Le TT, Gao F, Chan JX, Chong D, Ho KL, Tan BY,Ching CK, Teo WS, Tan JL, Liew R. Fragmented QRS complexes predict rightventricular dysfunction and
outflow tract aneurysms in patients with repaired tetralogy of Fallot. Int J Cardiol. 2013;167:1366–1372.
16. Park SJ, On YK, Kim JS, Park SW, Yang JH, Jun TG, Kang IS, Lee HJ, Choe YH,Huh J. Relation of fragmented QRS complex to right ventricular fibrosis
detected by late gadolinium enhancement cardiac magnetic resonance in adults with repaired tetralogy of fallot. Am J Cardiol. 2012;109:110–115.
Myocardial fibrosis/ scar
• Known to occur in repaired TOF—> RV dysfunction/ poor CV outcomes—
> HF/ arrhythmias/ death
• Deterioration in myocardial contraction+ relaxation—> Substrate for
arrhythmias
• CMR important in risk stratification
• QRS-f: A surrogate for myocardial fibrosis, predictive of all cause
mortality
• Bokma et al —> Had older pts with more co-morbidities—> Higher all
cause mortality (6 vs 12%)
• Good inter observer correlation—> Technique can be easily integrated
in daily clinical practice
Inter observer correlation
Clinical impact
• Several risk scores: Good predictive value in population from which
derived
• CMR/ cat: Not performed annually
• Annual evaluation needed: Risk changes over time
• ECG: Inexpensive/ available/ recommended as a part of routine
evaluation
Limitations
• Usage of all cause mortality instead of CV mortality as primary end
point
• If QRS-f postulated to be caused by myocardial fibrosis, vent
dysfunction+ arrhythmias—> Then, shud predict cv mortality without
much association with non cardiovascular mortality
• No correction was made for length of time each pt had QRS-f before
initial ECG—> Lead time bias
Conclusions
• Assessment of presence+ severity of QRS-f feasible in all pts—>
Reproduccible with good IO correlation, independently predictive of all
cause mortality
• ECG: Inexpensive/ easy to interpret/ available/ routinely obtained
• QRS-f: Readily available risk stratification for these pts, may be
complementary to existing risk scores
Food for further thinking…
• To evaluate temporal changes in extent of QRS-f
• If timely interventions based on these changes will improve outcomes
THANKZ…

More Related Content

What's hot

Amy l. Doneen: Imaging & Inflammation: Applying the Evidence to Clinical Prac...
Amy l. Doneen: Imaging & Inflammation: Applying the Evidence to Clinical Prac...Amy l. Doneen: Imaging & Inflammation: Applying the Evidence to Clinical Prac...
Amy l. Doneen: Imaging & Inflammation: Applying the Evidence to Clinical Prac...
Cleveland HeartLab, Inc.
 
Medtronic international the future of cardiac resynchronisation therapy
Medtronic international the future of cardiac resynchronisation therapyMedtronic international the future of cardiac resynchronisation therapy
Medtronic international the future of cardiac resynchronisation therapy
drucsamal
 
Ecg circulation 2006
Ecg circulation 2006Ecg circulation 2006
Ecg circulation 2006
gisa_legal
 
Identifying super responders to cardiac resynchronization therapy
Identifying super responders to cardiac resynchronization therapyIdentifying super responders to cardiac resynchronization therapy
Identifying super responders to cardiac resynchronization therapy
drucsamal
 
ICDs in nonischemic cardiomyopathy
ICDs in nonischemic cardiomyopathyICDs in nonischemic cardiomyopathy
ICDs in nonischemic cardiomyopathy
Sergio Pinski
 
Year in cardiology imaging 2019 - CMR
Year in cardiology imaging 2019 - CMRYear in cardiology imaging 2019 - CMR
Year in cardiology imaging 2019 - CMR
Praveen Nagula
 
Ensayos clínicos en IC preservada: resultados del PARAGON-HF
Ensayos clínicos en IC preservada: resultados del PARAGON-HFEnsayos clínicos en IC preservada: resultados del PARAGON-HF
Ensayos clínicos en IC preservada: resultados del PARAGON-HF
Sociedad Española de Cardiología
 
Surgical director heart transplant and mechanical assist device program
Surgical director heart transplant and mechanical assist device programSurgical director heart transplant and mechanical assist device program
Surgical director heart transplant and mechanical assist device program
drucsamal
 
Soledad ojeda novedades intervencionismo coronario
Soledad ojeda   novedades intervencionismo coronarioSoledad ojeda   novedades intervencionismo coronario
Soledad ojeda novedades intervencionismo coronario
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Prevention of contrast nephropathy,CIN.
Prevention of contrast nephropathy,CIN.Prevention of contrast nephropathy,CIN.
Prevention of contrast nephropathy,CIN.
Dr.Hasan Mahmud
 
Qrs and crt final in english
Qrs and crt final in englishQrs and crt final in english
Qrs and crt final in englishSergio Pinski
 
03 FFR Van Royen aimradial2017 - Pd/Pa and iFR
03 FFR Van Royen aimradial2017 - Pd/Pa and iFR03 FFR Van Royen aimradial2017 - Pd/Pa and iFR
Cardiac resynchronization therapy
Cardiac resynchronization therapyCardiac resynchronization therapy
Cardiac resynchronization therapy
Jose Osorio
 
Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapy
cardiologycases
 
Transcatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa forTranscatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa for
Hans Garcia
 
02 FFR Mamas aimradial2017 - Pd/Pa and FFR
02 FFR Mamas aimradial2017 - Pd/Pa and FFR02 FFR Mamas aimradial2017 - Pd/Pa and FFR

What's hot (20)

Amy l. Doneen: Imaging & Inflammation: Applying the Evidence to Clinical Prac...
Amy l. Doneen: Imaging & Inflammation: Applying the Evidence to Clinical Prac...Amy l. Doneen: Imaging & Inflammation: Applying the Evidence to Clinical Prac...
Amy l. Doneen: Imaging & Inflammation: Applying the Evidence to Clinical Prac...
 
Medtronic international the future of cardiac resynchronisation therapy
Medtronic international the future of cardiac resynchronisation therapyMedtronic international the future of cardiac resynchronisation therapy
Medtronic international the future of cardiac resynchronisation therapy
 
Ecg circulation 2006
Ecg circulation 2006Ecg circulation 2006
Ecg circulation 2006
 
Role of CRT and CRTD in CHF
Role of CRT and CRTD in CHFRole of CRT and CRTD in CHF
Role of CRT and CRTD in CHF
 
Identifying super responders to cardiac resynchronization therapy
Identifying super responders to cardiac resynchronization therapyIdentifying super responders to cardiac resynchronization therapy
Identifying super responders to cardiac resynchronization therapy
 
ICDs in nonischemic cardiomyopathy
ICDs in nonischemic cardiomyopathyICDs in nonischemic cardiomyopathy
ICDs in nonischemic cardiomyopathy
 
Year in cardiology imaging 2019 - CMR
Year in cardiology imaging 2019 - CMRYear in cardiology imaging 2019 - CMR
Year in cardiology imaging 2019 - CMR
 
Ensayos clínicos en IC preservada: resultados del PARAGON-HF
Ensayos clínicos en IC preservada: resultados del PARAGON-HFEnsayos clínicos en IC preservada: resultados del PARAGON-HF
Ensayos clínicos en IC preservada: resultados del PARAGON-HF
 
CCTGA dobutamine
CCTGA dobutamineCCTGA dobutamine
CCTGA dobutamine
 
Surgical director heart transplant and mechanical assist device program
Surgical director heart transplant and mechanical assist device programSurgical director heart transplant and mechanical assist device program
Surgical director heart transplant and mechanical assist device program
 
Soledad ojeda novedades intervencionismo coronario
Soledad ojeda   novedades intervencionismo coronarioSoledad ojeda   novedades intervencionismo coronario
Soledad ojeda novedades intervencionismo coronario
 
Prevention of contrast nephropathy,CIN.
Prevention of contrast nephropathy,CIN.Prevention of contrast nephropathy,CIN.
Prevention of contrast nephropathy,CIN.
 
Qrs and crt final in english
Qrs and crt final in englishQrs and crt final in english
Qrs and crt final in english
 
Lack of evidence in carotid stenosis
Lack of evidence in carotid stenosisLack of evidence in carotid stenosis
Lack of evidence in carotid stenosis
 
Carotid stenosis (cqc)
Carotid stenosis (cqc)Carotid stenosis (cqc)
Carotid stenosis (cqc)
 
03 FFR Van Royen aimradial2017 - Pd/Pa and iFR
03 FFR Van Royen aimradial2017 - Pd/Pa and iFR03 FFR Van Royen aimradial2017 - Pd/Pa and iFR
03 FFR Van Royen aimradial2017 - Pd/Pa and iFR
 
Cardiac resynchronization therapy
Cardiac resynchronization therapyCardiac resynchronization therapy
Cardiac resynchronization therapy
 
Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapy
 
Transcatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa forTranscatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa for
 
02 FFR Mamas aimradial2017 - Pd/Pa and FFR
02 FFR Mamas aimradial2017 - Pd/Pa and FFR02 FFR Mamas aimradial2017 - Pd/Pa and FFR
02 FFR Mamas aimradial2017 - Pd/Pa and FFR
 

Similar to QRS FRAGMENTATION: ADULT TETROLOGY OF FALLOT

Severeasymtomaticas
SevereasymtomaticasSevereasymtomaticas
Severeasymtomaticas
escts2012
 
Dilated cardiomyopathy
Dilated cardiomyopathyDilated cardiomyopathy
Dilated cardiomyopathy
drucsamal
 
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY
ARRHYTHMOGENIC  RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHYARRHYTHMOGENIC  RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY
SR,CARDIOLOGY,JIPMER,PUDUCHERRY
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
Dr. Rohan Sonawane
 
Bicuspid Aortic Valve and Aortopathy
Bicuspid Aortic Valve and AortopathyBicuspid Aortic Valve and Aortopathy
Bicuspid Aortic Valve and Aortopathy
Cheng He
 
3 pe vietnam
3 pe vietnam3 pe vietnam
3 pe vietnam
Bác sĩ nhà quê
 
Scd
Scd Scd
Crt seminar
Crt seminarCrt seminar
Crt seminar
Ashweenkaur7
 
SurgeryDissection.pdf
SurgeryDissection.pdfSurgeryDissection.pdf
SurgeryDissection.pdf
Dicky A Wartono
 
Left-Right Shunt Natural history & Principles of Management
Left-Right ShuntNatural history & Principles of ManagementLeft-Right ShuntNatural history & Principles of Management
Left-Right Shunt Natural history & Principles of Managementdrranjithmp
 
Bon Secours Heart Valve Center
Bon Secours Heart Valve CenterBon Secours Heart Valve Center
Bon Secours Heart Valve Center
faminteractive
 
19 Ruzsa aimradial20170922 Valvuloplasty BAV
19 Ruzsa aimradial20170922 Valvuloplasty BAV19 Ruzsa aimradial20170922 Valvuloplasty BAV
Rev katz valve 2014 h&vi annual conf
Rev katz valve 2014 h&vi annual confRev katz valve 2014 h&vi annual conf
Rev katz valve 2014 h&vi annual conf
Meg Neal
 
La enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedadesLa enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedades
Sociedad Española de Cardiología
 
Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapycardiologycases
 
Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapycardiologycases
 
Cardiac Resynchronisation Therapy
Cardiac  Resynchronisation  TherapyCardiac  Resynchronisation  Therapy
Cardiac Resynchronisation Therapycardiologycases
 
Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapycardiologycases
 

Similar to QRS FRAGMENTATION: ADULT TETROLOGY OF FALLOT (20)

Severeasymtomaticas
SevereasymtomaticasSevereasymtomaticas
Severeasymtomaticas
 
Dilated cardiomyopathy
Dilated cardiomyopathyDilated cardiomyopathy
Dilated cardiomyopathy
 
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY
ARRHYTHMOGENIC  RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHYARRHYTHMOGENIC  RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Bicuspid Aortic Valve and Aortopathy
Bicuspid Aortic Valve and AortopathyBicuspid Aortic Valve and Aortopathy
Bicuspid Aortic Valve and Aortopathy
 
3 pe vietnam
3 pe vietnam3 pe vietnam
3 pe vietnam
 
Scd
Scd Scd
Scd
 
Crt seminar
Crt seminarCrt seminar
Crt seminar
 
Vogel endothelial function cv es
Vogel endothelial function   cv esVogel endothelial function   cv es
Vogel endothelial function cv es
 
SurgeryDissection.pdf
SurgeryDissection.pdfSurgeryDissection.pdf
SurgeryDissection.pdf
 
Left-Right Shunt Natural history & Principles of Management
Left-Right ShuntNatural history & Principles of ManagementLeft-Right ShuntNatural history & Principles of Management
Left-Right Shunt Natural history & Principles of Management
 
Bon Secours Heart Valve Center
Bon Secours Heart Valve CenterBon Secours Heart Valve Center
Bon Secours Heart Valve Center
 
Dr falk's slides part ii
Dr falk's slides  part iiDr falk's slides  part ii
Dr falk's slides part ii
 
19 Ruzsa aimradial20170922 Valvuloplasty BAV
19 Ruzsa aimradial20170922 Valvuloplasty BAV19 Ruzsa aimradial20170922 Valvuloplasty BAV
19 Ruzsa aimradial20170922 Valvuloplasty BAV
 
Rev katz valve 2014 h&vi annual conf
Rev katz valve 2014 h&vi annual confRev katz valve 2014 h&vi annual conf
Rev katz valve 2014 h&vi annual conf
 
La enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedadesLa enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedades
 
Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapy
 
Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapy
 
Cardiac Resynchronisation Therapy
Cardiac  Resynchronisation  TherapyCardiac  Resynchronisation  Therapy
Cardiac Resynchronisation Therapy
 
Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapy
 

More from Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology

PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIASPEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
FETAL CARDIAC SCREENING
FETAL CARDIAC SCREENINGFETAL CARDIAC SCREENING
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIASSYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
PEDIATRIC CARDIOLOGY CASE SCENARIOS
PEDIATRIC CARDIOLOGY CASE SCENARIOSPEDIATRIC CARDIOLOGY CASE SCENARIOS
PEDIATRIC CARDIOLOGY CASE SCENARIOS
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL) PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASESLONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
WHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
WHEN TO REFER TO A PEDIATRIC CARDIOLOGISTWHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
WHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWSPEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTIONWHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
PEDAITRIC OBESITY AND HYPERLIPEDEMIA
PEDAITRIC OBESITY AND HYPERLIPEDEMIAPEDAITRIC OBESITY AND HYPERLIPEDEMIA
PEDAITRIC OBESITY AND HYPERLIPEDEMIA
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 

More from Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology (20)

PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIASPEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
 
FETAL CARDIAC SCREENING
FETAL CARDIAC SCREENINGFETAL CARDIAC SCREENING
FETAL CARDIAC SCREENING
 
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIASSYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
 
PEDIATRIC CARDIOLOGY CASE SCENARIOS
PEDIATRIC CARDIOLOGY CASE SCENARIOSPEDIATRIC CARDIOLOGY CASE SCENARIOS
PEDIATRIC CARDIOLOGY CASE SCENARIOS
 
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL) PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
 
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASESLONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
 
WHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
WHEN TO REFER TO A PEDIATRIC CARDIOLOGISTWHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
WHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
 
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWSPEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
 
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTIONWHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
 
PEDAITRIC OBESITY AND HYPERLIPEDEMIA
PEDAITRIC OBESITY AND HYPERLIPEDEMIAPEDAITRIC OBESITY AND HYPERLIPEDEMIA
PEDAITRIC OBESITY AND HYPERLIPEDEMIA
 
Micronutrient deficiency In Children
Micronutrient deficiency In ChildrenMicronutrient deficiency In Children
Micronutrient deficiency In Children
 
DYSBIOSIS IN CHILDREN BORN BY CAESAREAN SECTION
DYSBIOSIS IN CHILDREN BORN BY CAESAREAN SECTIONDYSBIOSIS IN CHILDREN BORN BY CAESAREAN SECTION
DYSBIOSIS IN CHILDREN BORN BY CAESAREAN SECTION
 
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
 
Heart diseases in children
Heart diseases in childrenHeart diseases in children
Heart diseases in children
 
ICCU ECGs
ICCU ECGsICCU ECGs
ICCU ECGs
 
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACHCONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
 
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
 
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
 
Cath meet 25020202 (TGA, VSD, PS FOR PA PRESSURES)
Cath meet   25020202 (TGA, VSD, PS FOR PA PRESSURES)Cath meet   25020202 (TGA, VSD, PS FOR PA PRESSURES)
Cath meet 25020202 (TGA, VSD, PS FOR PA PRESSURES)
 
Cath meet 03022020 (VSD PAH FOR REVERSIBILITY, PVR)
Cath meet 03022020 (VSD PAH FOR REVERSIBILITY, PVR)Cath meet 03022020 (VSD PAH FOR REVERSIBILITY, PVR)
Cath meet 03022020 (VSD PAH FOR REVERSIBILITY, PVR)
 

Recently uploaded

basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 

Recently uploaded (20)

basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 

QRS FRAGMENTATION: ADULT TETROLOGY OF FALLOT

  • 2. Role of QRS fragmentation for risk stratification in adults with TOF J Am Heart Assoc., Nov 2018
  • 3. Introduction • Adults with repaired TOF—> Reduced survival compared to general population • 30 yrs survival: 85-90% • Risk stratification imp—> To identify+ treat patients with high risk of CV death • 2. Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, McGoon DC,Kirklin JW, Danielson GK. Long-term outcome in patients undergoing surgicalrepair of tetralogy of Fallot. N Engl J Med. 1993;329:593–599. 3. Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Schreier J, GatzoulisMA, Groenink M, Inuzuka R, Kilner PJ, Koyak Z, Landzberg MJ, Mulder B, Powell AJ, Wald R, Geva T. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014;100:247–253. 4. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Longterm survival in patients with repair of tetralogy of Fallot: 36-year follow-up of490 survivors of the first year after surgical repair. J Am Coll Cardiol.1997;30:1374–1383. 5. Katz NM, Blackstone EH, Kirklin JW, Pacifico AD, Bargeron LM Jr. Late survival and symptoms after repair of tetralogy of Fallot. Circulation. 1982;65: 403–410.
  • 4. Intro cont… • Proposed risk factors for mortality in aduts with repaired TOF: • Age at time of repair • LV/ RV dysfunction • RV fibrosis/ RVH • Ventricular arrhythmias • Increased LVEDP
  • 5. Intro cont… • Available risk scores includes variables from CMR/ Cardiac cath—> Not routinely performed during annual evaluation • ECG: Inexpensive/ Non invasive/ Readily available/ Routinely performed during annual examination • 2017: Bokma et al: QRS-f reliably predicts mortality in this population • Bokma JP, Winter MM, Vehmeijer JT, Vliegen HW, van Dijk AP, van Melle JP,Meijboom FJ, Post MC, Zwinderman AH, Mulder BJ, Bouma BJ. QRSfragmentation is superior to QRS duration in predicting mortality in adultswith tetralogy of Fallot. Heart. 2017;103:666–671.
  • 6. Aim of study… • To determine whether QRS-f derived from a standard 12 leads ECG could independently predict mortality in a different population of adults with TOF
  • 7. Patient selection… • Mayo adult CHD database • > 18 y, repaired TOF • At least 1 ECG b/w 1/1/1990 to 31/12/2017 (28 y) • PA: Excluded
  • 8. Data collection… • Clinical notes/ ECG/ Holter/ ECHO/ Exercise test/ Surgical records/ CMR—> Reviewed • 1st ECG during study period: Baseline—> Used for assessment of QRS-f • Clinical data obtained within 12 months of baseline ECG—> Baseline characteristics • ECGs analysed by 2 observers: NM/ MF—> Blinded—> If discordance—> 3rd assesses AD
  • 9. QRS-f • If QRS duration < 120 ms: • An additional R wave (R’) or notch in nadir of S in ≥ 2 contagious leads • Rt sided/ septal: aVR, V1, V2 • Anterior: V2-V5 • Lateral: I, aVL, V5, V6 • Inferior: II, III, aVF • In pts with RBBB: • ≥ 3 R waves/ notes in R/S complexes in ≥2 contiguous leads • In pts with paced QRS+ PVC: • ≥ 3 notches in the R/S complexes
  • 10. QRS-f
  • 11. QRS-f Severity • No of leads with QRS-f: • NONE • MILD: ≤ 3 leads • MODERATE: 4 leads • SEVERE: ≥5 leads • For assessment of progression of QRS-f: Review of ECGs in its with at least 5 years of follow up
  • 12. Results • 465 pts • Age at time of baseline ECG: 37 ± 14y • 223 (48%): Men • 41 (9%): Pacemakers • 58 (13%): Defibrillators • 100 (22%): H/o VT
  • 13.
  • 14.
  • 15. ECG • Baseline ECG rhythm: • Sinus: 407 (88%) • Atrial flutter/ tachycardia: 20 (4%) • Atrial and/ or ventricular paced rhythm: 21 (5%) • HR: 74 ± 9bpm • QRS duration: 148± 33ms • QRS morphology: • Normal: 9 (2%) • iRBBB: 102 (22%) • RBBB: 354 (76%)
  • 16. ECG cont… • QRS-f: 161 (35%) • Mild: 43 (9%) • Moderate: 77(17%) • Severe: 41 (9%) • Pts with QRS-f: • Had longer QRS durations: 167±31 vs 126±24 ms, p=0.001 • Were older at time of repair: 7±6 vs 4±3y, p=0.023 • 371 (80%): ECG at 5 y follow up • 39 (11%): Progression of QRS-f (No—> Mild: 34; Mild —> MODERATE: 5)
  • 17. Outcomes • 55 deaths: 12%; Follow up period: 13.6±8.2 y • CHF: 13 (24%) • Arrhythmic/ sudden death: 11 (20%) • Post op death after cardiac sx: 3 (6%) • MODS by sepsis:4 (7%) • Malignancy: 5 (9%) • GI bleed: 1 (2%) • Stroke: 2 (4%) • Unknown/ Mixed: 16 (29%)
  • 18. Outcomes cont… • 20 yrs survival: • Group without QRS-f: 97% • Mild QRS-f: 93%; p=0.643 • Moderate QRS-f: 82%; p=0.031 • Severe QRS-f: 33%; p<0.001 • Severity of QRS-f: An independent predictor for all cause mortality after adjustment for other ECG parameters, pt demographics, vent. Function and h/o atrial/ ventricular arrhythmias
  • 19. Discussion • QRS duration> 180 ms: Risk factor of sudden death • Bokma et al: QRS-f superior in prediction of all cause mortality • This study: In a different population (US vs Dutch) • Moderate/ severe QRS-f: 2 fold increase in risk of all cause mortality, had reduced 20y survival
  • 20. QRS-f as a marker of ventricular dysfunction • Studies with QRS-f of lt precordial leads—> Associated with myocardial scar + LV aneurysm in its with CAD (Severity co-relates with extent of scar) • QRS-f in anterior leads—> Associated with RV dysfunction+ RVOT aneurysm in TOF pts • A marker of myocardial fibrosis—> LGE in CMR • Das MK, Khan B, Jacob S, Kumar A, Mahenthiran J. Significance of a fragmented QRS complex versus a Q wave in patients with coronary arterydisease. Circulation. 2006;113:2495–2501. 14. Reddy CV, Cheriparambill K, Saul B, Makan M, Kassotis J, Kumar A, Das MK.Fragmented left sided QRS in absence of bundle branch block: sign of leftventricular aneurysm. Ann Noninvasive Electrocardiol. 2006;11:132–138. 15. Shanmugam N, Yap J, Tan RS, Le TT, Gao F, Chan JX, Chong D, Ho KL, Tan BY,Ching CK, Teo WS, Tan JL, Liew R. Fragmented QRS complexes predict rightventricular dysfunction and outflow tract aneurysms in patients with repaired tetralogy of Fallot. Int J Cardiol. 2013;167:1366–1372. 16. Park SJ, On YK, Kim JS, Park SW, Yang JH, Jun TG, Kang IS, Lee HJ, Choe YH,Huh J. Relation of fragmented QRS complex to right ventricular fibrosis detected by late gadolinium enhancement cardiac magnetic resonance in adults with repaired tetralogy of fallot. Am J Cardiol. 2012;109:110–115.
  • 21. Myocardial fibrosis/ scar • Known to occur in repaired TOF—> RV dysfunction/ poor CV outcomes— > HF/ arrhythmias/ death • Deterioration in myocardial contraction+ relaxation—> Substrate for arrhythmias • CMR important in risk stratification • QRS-f: A surrogate for myocardial fibrosis, predictive of all cause mortality • Bokma et al —> Had older pts with more co-morbidities—> Higher all cause mortality (6 vs 12%) • Good inter observer correlation—> Technique can be easily integrated in daily clinical practice
  • 23. Clinical impact • Several risk scores: Good predictive value in population from which derived • CMR/ cat: Not performed annually • Annual evaluation needed: Risk changes over time • ECG: Inexpensive/ available/ recommended as a part of routine evaluation
  • 24. Limitations • Usage of all cause mortality instead of CV mortality as primary end point • If QRS-f postulated to be caused by myocardial fibrosis, vent dysfunction+ arrhythmias—> Then, shud predict cv mortality without much association with non cardiovascular mortality • No correction was made for length of time each pt had QRS-f before initial ECG—> Lead time bias
  • 25. Conclusions • Assessment of presence+ severity of QRS-f feasible in all pts—> Reproduccible with good IO correlation, independently predictive of all cause mortality • ECG: Inexpensive/ easy to interpret/ available/ routinely obtained • QRS-f: Readily available risk stratification for these pts, may be complementary to existing risk scores
  • 26. Food for further thinking… • To evaluate temporal changes in extent of QRS-f • If timely interventions based on these changes will improve outcomes